Trademark: 90039158
Status Date
Thursday, December 9, 2021
Filing Date
Tuesday, July 7, 2020
Abandoned Date
Tuesday, November 30, 2021
44 Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic cutaneous melanoma, namely genetic expression profiling and gene sequencing relating to dermatological cutaneous melanoma, and providing medical information; and providing information for risk of metastasis and diagnostic support thereby effecting changes in treatment plans
CONFIRM DX-CM
CONFIRM MEDICS CM
CONFIRM DIAGNOSIS CUTANEOUS MELANOMA
Dec 9, 2021
Abandonment Notice E-Mailed - Failure To Respond
Dec 9, 2021
Abandonment - Failure To Respond Or Late Response
May 28, 2021
Notification Of Final Refusal Emailed
May 28, 2021
Final Refusal E-Mailed
May 28, 2021
Final Refusal Written
Apr 19, 2021
Assigned To Examiner
Apr 14, 2021
Teas/Email Correspondence Entered
Apr 14, 2021
Correspondence Received In Law Office
Apr 14, 2021
Teas Response To Office Action Received
Oct 16, 2020
Notification Of Non-Final Action E-Mailed
Oct 16, 2020
Non-Final Action E-Mailed
Oct 16, 2020
Non-Final Action Written
Oct 15, 2020
Assigned To Examiner
Aug 3, 2020
New Application Office Supplied Data Entered In Tram
Jul 10, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
